These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 617787

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B, Griffin JH.
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of an automatic clot-sensing instrument : Coag A Pet 200 (author's transl)].
    Houbouyan L, Roussi J, Goguel A.
    Nouv Rev Fr Hematol (1978); 1978 Jun 10; 20(2):199-208. PubMed ID: 704336
    [Abstract] [Full Text] [Related]

  • 6. [The physiology of blood platelets].
    Lüscher EF.
    Schweiz Med Wochenschr; 1968 Oct 19; 98(42):1629-35. PubMed ID: 5698340
    [No Abstract] [Full Text] [Related]

  • 7. Therapeutic materials used in the treatment of coagulation defects.
    Smith JK, Bidwell E.
    Clin Haematol; 1979 Feb 19; 8(1):183-206. PubMed ID: 367662
    [No Abstract] [Full Text] [Related]

  • 8. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.).
    Murano G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972 Feb 19; 97(1):5-19. PubMed ID: 4114585
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bovine plasma thromboplastin antecedent (Factor XI) deficiency.
    Kociba GJ, Ratnoff OD, Loeb WF, Wall RL, Heider LE.
    J Lab Clin Med; 1969 Jul 19; 74(1):37-41. PubMed ID: 5256172
    [No Abstract] [Full Text] [Related]

  • 11. [BLOOD CLOTTING FACTOR IN HEMOLYSATES].
    OGIWARA Y.
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec 19; 26():779-87. PubMed ID: 14154695
    [No Abstract] [Full Text] [Related]

  • 12. Testing for potential thrombogenicity of prothrombin complex concentrates.
    Snape TJ.
    Dev Biol Stand; 1979 Dec 19; 44():199-204. PubMed ID: 544295
    [Abstract] [Full Text] [Related]

  • 13. Characterization of procoagulants produced in cell cultures by tests of coagulation.
    Zacharski LR, McIntyre OR.
    Thromb Diath Haemorrh; 1971 Dec 31; 26(3):493-502. PubMed ID: 5144962
    [No Abstract] [Full Text] [Related]

  • 14. [Thrombogenicity of a new prothrombin complex concentrate].
    Klöcking HP, Klessen C, Jablonowski C, Meerbach W, Dornheim G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Dec 31; 111(5):645-61. PubMed ID: 6083940
    [Abstract] [Full Text] [Related]

  • 15. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW, Abildgaard C, Shitanishi KT, Harrison J, Gendler S, Heldebrant CM.
    J Lab Clin Med; 1993 Mar 31; 121(3):394-405. PubMed ID: 8445288
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prothrombin complex concentrates: preparation, properties, and clinical uses.
    White GC, Lundblad RL, Kingdon HS.
    Curr Top Hematol; 1979 Mar 31; 2():203-44. PubMed ID: 318075
    [No Abstract] [Full Text] [Related]

  • 20. PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY: A CASE REPORT.
    IDA M, TANAKA M.
    Shonika Kiyo; 1963 Mar 31; 9():297-301. PubMed ID: 14112922
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.